VERSUCHE ZUR ERKENNUNG SPEZIFISCHER SENSIBILISIERUNG GEGENUEBER TUMORANTIGENEN DURCH MESSUNG PASSIV ELEKTRISCHER SUMMENEFFEKTE IM VERGLEICH ZUM ELEKTROPHORESE-MOBILITAETSTEST = EXPERIENCES POUR METTRE EN EVIDENCE UNE SENSIBILISATION SPECIFIQUE CONTRE LES ANTIGENES TUMORAUX EN MESURANT LES EFFETS ADDITIFS ELECTRIQUES PASSIFS COMPARATIVEMENT AU TEST DE MOBILITE ELECTROPHORETIQUEEMMRICH F; PLIQUETT F; WUNDERLICH S et al.1978; ACTA BIOL. MED. GERM.; DDR; DA. 1978; VOL. 37; NO 8; PP. 1267-1272; ABS. ENG; BIBL. 14 REF.Article

UNTERSUCHUNGEN ZUR IMMUNOLOGISCHEN. SPEZIFITAET DES MAKROPHAGEN. ELEKTROPHORESE. MOBILITAETSTESTS BEI MAMMAKARZINOM. TRANSPLANTATION. = RECHERCHES SUR LA SPECIFICITE IMMUNOLOGIQUE DU TEST DE MOBILITE ELECTROPHORETIQUE DES MACROPHAGES CHEZ DES SOURIS AVEC DES TRANSPLANTS SYNGENIQUES ET ALLOGENIQUES DE TUMEUR MAMMAIREKOTZSCH M; IRMSCHER J; FISCHER R et al.1976; ACTA BIOL. MED. GERM.; ALLEM.; DA. 1976; VOL. 35; NO 12; PP. 1749-1753; ABS. ANGL.; BIBL. 15 REF.Article

LEUCOCYTE MIGRATION INHIBITION UNDER AGAROSE VERSUS MEM TEST FOR DETECTION OF TUMOUR-ASSOCIATED ANTIGENS.EMMRICH F; IRMSCHER J; KOTZSCH M et al.1978; BRIT. J. CANCER; GBR; DA. 1978; VOL. 37; NO 3; PP. 461-465; BIBL. 16 REF.Article

A human lymphokine released by mononuclear blood cells upon contact with CEAMÜLLER, M; GROSSMANN, H; WAGNER, H et al.Immunology letters. 1986, Vol 12, Num 2-3, pp 159-164, issn 0165-2478Article

An ELISA for tissue factor using monoclonal antibodiesALBRECHT, S; LUTHER, T; GROSSMANN, H et al.Blood coagulation & fibrinolysis. 1992, Vol 3, Num 3, pp 263-270, issn 0957-5235Article

Constitutive tissue factor expression of human breast cancer cell line MCF-7 is modulated by growth factorsFLÖSSEL, C; LUTHER, T; ALBRECHT, S et al.European journal of cancer. Part A. 1992, Vol 28, Num 12, pp 1999-2002Article

Bedeutung von Rezeptoren des Gerinnungs- und Fibrinolysesystems für die Tumorbiologie : Kreibsleiden : Aktuelle Diagnostik und Therapie = Biological significance of receptors of the coagulation and fibrinolysis systems in cancer : Cancerous disease : Actual diagnostics and therapyLUTHER, T; KOTZSCH, M; ALBRECHT, S et al.Wissenschaftliche Zeitschrift der Technischen Universität Dresden. 1997, Vol 46, Num 4, pp 23-25, issn 0043-6925Article

Diagnostische DNA-Zytometrie an Mammakarzinomen : Kreibsleiden : Aktuelle Diagnostik und Therapie = Diagnostic DNA-cytometry in breast carcinomas : Cancerous disease : Actual diagnostics and therapyKUNZE, D; DIMMER, V; HAROSKE, G et al.Wissenschaftliche Zeitschrift der Technischen Universität Dresden. 1997, Vol 46, Num 4, pp 18-19, issn 0043-6925Article

Detection of circulating tissue factor and factor VII in a normal populationALBRECHT, S; KOTZSCH, M; SIEGERT, G et al.Thrombosis and haemostasis. 1996, Vol 75, Num 5, pp 772-777, issn 0340-6245Article

Functional implications of tissue factor localization to cell-cell contacts in myocardiumLUTHER, T; DITTERT, D.-D; KOTZSCH, M et al.Journal of pathology. 2000, Vol 192, Num 1, pp 121-130, issn 0022-3417Article

Effect of human recombinant interleukin-6 and interleukin-8 on monocyte procoagulant activityNEUMANN, F.-J; OTT, I; MARX, N et al.Arteriosclerosis, thrombosis, and vascular biology. 1997, Vol 17, Num 12, pp 3399-3405, issn 1079-5642Article

Are overexpressed alternative survivin transcripts in human bladder cancer suitable targets for siRNA-mediated in vitro inhibition?WUTTIG, D; KUNZE, D; HAKENBERG, O. W et al.International journal of oncology. 2007, Vol 30, Num 6, pp 1317-1324, issn 1019-6439, 8 p.Article

Epitope mapping of monoclonal antibodies directed to PAI-1 using PAI-1/PAI-2 chimera and PAI-1-derived synthetic peptidesMUEHLENWEG, B; GUTHAUS, E; MAGDOLEN, V et al.Thrombosis research. 2000, Vol 98, Num 1, pp 73-81, issn 0049-3848Article

Co-detection of members of the urokinase plasminogen activator system in tumour tissue and serum correlates with a poor prognosis for soft-tissue sarcoma patientsTAUBERT, H; WÜRL, P; MAGDOLEN, V et al.British journal of cancer. 2010, Vol 102, Num 4, pp 731-737, issn 0007-0920, 7 p.Article

Cathepsin B, plasminogenactivator-inhibitor (PAI-1) and plasminogenactivator-receptor (uPAR) are prognostic factors for patients with non-small cell lung cancerWERLE, B; KOTZSCH, M; MAGDOLEN, V et al.Anticancer research. 2004, Vol 24, Num 6, pp 4147-4161, issn 0250-7005, 15 p.Article

New ELISA for quantitation of human urokinase receptor (CD87) in cancerKOTZSCH, M; LUTHER, T; GROSSER, M et al.International journal of oncology. 2000, Vol 17, Num 4, pp 827-834, issn 1019-6439Article

Tissue factor antigen is elevated in patients with microvascular complications of diabetes mellitusZUMBACH, M; HOFMANN, M; WAHL, P et al.Experimental and clinical endocrinology & diabetes. 1997, Vol 105, Num 4, pp 206-212, issn 0947-7349Conference Paper